These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11519732

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathophysiological role of calpain in experimental demyelination.
    Shields DC, Banik NL.
    J Neurosci Res; 1999 Mar 01; 55(5):533-41. PubMed ID: 10082076
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Putative role of calpain in the pathophysiology of experimental optic neuritis.
    Shields DC, Banik NL.
    Exp Eye Res; 1998 Oct 01; 67(4):403-10. PubMed ID: 9820787
    [Abstract] [Full Text] [Related]

  • 7. Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis.
    Shields DC, Tyor WR, Deibler GE, Hogan EL, Banik NL.
    Proc Natl Acad Sci U S A; 1998 May 12; 95(10):5768-72. PubMed ID: 9576959
    [Abstract] [Full Text] [Related]

  • 8. Calpain, a mediator of myelin breakdown in demyelinating diseases.
    Shields DC, Deibler GE, Banik NL.
    Ann N Y Acad Sci; 1997 Oct 15; 825():128-30. PubMed ID: 9369981
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis.
    Das A, Guyton MK, Butler JT, Ray SK, Banik NL.
    CNS Neurol Disord Drug Targets; 2008 Jun 15; 7(3):313-20. PubMed ID: 18673215
    [Abstract] [Full Text] [Related]

  • 14. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain.
    Shields DC, Schaecher KE, Saido TC, Banik NL.
    Proc Natl Acad Sci U S A; 1999 Sep 28; 96(20):11486-91. PubMed ID: 10500203
    [Abstract] [Full Text] [Related]

  • 15. A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models.
    Haque A, Trager NNM, Butler JT, Das A, Zaman V, Banik NL.
    Neurochem Int; 2024 May 28; 175():105697. PubMed ID: 38364938
    [Abstract] [Full Text] [Related]

  • 16. Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis.
    Dunham J, Bauer J, Campbell GR, Mahad DJ, van Driel N, van der Pol SMA, 't Hart BA, Lassmann H, Laman JD, van Horssen J, Kap YS.
    J Neuropathol Exp Neurol; 2017 Jun 01; 76(6):467-478. PubMed ID: 28505283
    [Abstract] [Full Text] [Related]

  • 17. Calpain secreted by activated human lymphoid cells degrades myelin.
    Deshpande RV, Goust JM, Hogan EL, Banik NL.
    J Neurosci Res; 1995 Oct 01; 42(2):259-65. PubMed ID: 8568927
    [Abstract] [Full Text] [Related]

  • 18. Immunological and cytological studies of autoimmune demyelination and multiple sclerosis.
    Colover J.
    Brain Behav Immun; 1988 Dec 01; 2(4):341-5. PubMed ID: 3076485
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Copper chelation and autoimmunity differentially impact myelin in the hippocampal-prefrontal circuit.
    Nickel M, Eid F, Jukkola P, Gu C.
    J Neuroimmunol; 2019 Sep 15; 334():576998. PubMed ID: 31254928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.